Document is current
Any future updates will be listed below
-
Authors
Miyagawa-Hayashino, Aya
Yoshifuji, Hajime
Kitagori, Koji
Ito, Shinji
Oku, Takuma
Hirayama, Yoshitaka
Salah, Adeeb
Nakajima, Toshiki
Kiso, Kaori
Yamada, Norishige
Haga, Hironori
Tsuruyama, Tatsuaki
-
Funding
Funding for this research was provided by:
Promoting Science and Technology of the Japanese Government
grants from the Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
-
More Information
Article History
Received: 18 January 2017
Accepted: 2 January 2018
First Online: 30 January 2018
Authors’ information
: Not applicable.
: Written informed content was obtained from all study participants, and the study was conducted according to the principles expressed in the Declaration of Helsinki. The Ethics Committee of Kyoto University approved this study (Nos. E1872, G520).Mice were maintained under specific pathogen-free conditions at the Center for Experimental Animals of Kyoto University, and the animal experiments were performed in accordance with the institutional guidelines.
: Not applicable.
: TO and YH are employees of Astellas Pharma Inc. This does not alter our adherence to journal policies on sharing data and materials. Astellas Pharma Inc. had no role in the study design or collection, or analysis or interpretation of the data; writing of the manuscript; or the decision to submit the manuscript for publication. Publication of this article was approved by an intellectual property committee composed of representatives from Kyoto University and Astellas Pharma Inc.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
